Skip to main content
. Author manuscript; available in PMC: 2019 Jul 9.
Published in final edited form as: Cancer Cell. 2018 May 3;34(1):9–20. doi: 10.1016/j.ccell.2018.03.023

Figure 1. The consequences of CDK4/6 inhibition.

Figure 1

The four cellular mechanisms, labeled A-D, that contribute to the efficacy of CDK4/6 inhibitors are shown. Details are in the accompanying text.